Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/7446| SARS-CoV-2 T cell responses are expected to remain robust against Omicron | |
| Syed Faraz Ahmed Ahmed Abdul Quadeer Matthew McKay | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| https://doi.org/10.1101/2021.12.12.472315 | |
| https://www.biorxiv.org/content/10.1101/2021.12.12.472315v1.article-info | |
| Omicron, the most recent SARS-CoV-2 variant of concern (VOC), harbours multiple mutations in the spike protein that were not observed in previous VOCs. Initial studies suggest Omicron to substantially reduce the neutralizing capability of antibodies induced from vaccines and previous infection. However, its effect on T cell responses remains to be determined. Here, we assess the effect of Omicron mutations on known T cell epitopes and report data suggesting T cell responses to remain broadly robust against this new variant. | |
| medRxiv and bioRxiv | |
| 12-12-2021 | |
| Preimpreso | |
| https://www.biorxiv.org/content/10.1101/2021.12.12.472315v1 | |
| Inglés | |
| Epidemia COVID-19 | |
| Investigadores Público en general | |
| VIRUS RESPIRATORIOS | |
| Versión publicada | |
| publishedVersion - Versión publicada | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| SARS COV2 T Cell responses are expected to remain robust against Omicron.pdf | 335.09 kB | Adobe PDF | Visualizar/Abrir |